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E-mail address: david.vawdrey@dbmi.columbia.edObjective: To measure the rate of non-publication and assess possible publication bias in clinical trials of
electronic health records.
Methods: We searched ClinicalTrials.gov to identify registered clinical trials of electronic health records
and searched the biomedical literature and contacted trial investigators to determine whether the results
of the trials were published. Publications were judged as positive, negative, or neutral according to the
primary outcome.
Results: Seventy-six percent of trials had publications describing trial results; of these, 74% were positive,
21% were neutral, and 4% were negative (harmful). Of unpublished studies for which the investigator
responded, 43% were positive, 57% were neutral, and none were negative; the lower rate of positive
results was signiﬁcant (p < 0.001).
Conclusion: The rate of non-publication in electronic health record studies is similar to that in other bio-
medical studies. There appears to be a bias toward publication of positive trials in this domain.
 2012 Elsevier Inc. All rights reserved.1. Background
Publication bias refers to the selective publication or suppression
of research results according to outcome. In multiple scientiﬁc do-
mains, there has been a greater likelihood for publication when
studies have positive results [1–3]. A recent review assessed the ef-
fect of health information technology on care quality, efﬁciency, and
provider satisfaction, ﬁnding that 92% of articles reached conclu-
sions that were positive [4]. Although the positive ﬁndings associ-
ated with health information technology adoption are encouraging
for those implementing electronic health records, we hypothesized
that the true rate of positive results in trials of electronic health re-
cords may differ from the published rate due to publication bias.
Advance registration of clinical trials has been introduced as a
method to reduce publication bias by making available a catalog
of the trials that are less likely to be published due to neutral or
negative results [5]. ClinicalTrials.gov is an information resource
maintained by the United States National Library of Medicine that
provides a registry of both federally and privately funded clinical
trials since February 2000. Journals whose editors belong to the
International Committee of Medical Journal Editors (ICMJEs) will
only publish clinical trial results if the trial is registered with Clin-
icalTrials.gov or another ICMJE approved trial registry before the
ﬁrst patient is recruited [6].ll rights reserved.
omedical Informatics, Colum-
t, VC5, New York, NY 10032,
u (D.K. Vawdrey).When the ICMJE adopted the policy requiring registration of
clinical trials, they noted that only ClinicalTrials.gov met their stan-
dards for free public access, completeness and validity of the regis-
tration data, electronic search capability [7]. While other registries
exist (notably the International Standard Randomised Controlled
Trial Number [8]), ClinicalTrials.gov appears to be the preferred
Web site for posting clinical trials [9]. A US federal law enacted
in 2007 mandates ClinicalTrials.gov registration and basic results
reporting for interventional studies of drugs, biological products,
and devices, regardless of sponsor or funding source [10].
We hypothesized that ClinicalTrials.gov could be used to exam-
ine potential publication bias in studies of electronic health records
(EHRs), based on the number of completed clinical trials that were
never published. We recognize that not all EHR studies are regis-
tered in ClinicalTrials.gov. For example, ICMJE guidelines may not
apply where the unit of randomization in a trial is the healthcare
system or care delivery location as opposed to an individual human
subject. Moreover, while any study can be registered with Clinical-
Trials.gov, studies that are observational, or that lack a control
group, are less likely to be registered than other trials. Neverthe-
less, ClinicalTrials.gov is a convenient, publicly available repository
of trial information that can provide an estimate of publication
rates related to EHR studies.
2. Methods
We queried ClinicalTrials.gov for clinical trials of electronic
health records using the following search phrases: ‘‘electronic
health records,’’ ‘‘electronic medical records,’’ ‘‘electronic
Table 1
Disposition of completed trials of electronic health records registered in ClinicalTri-
als.gov from 2000 to 2008.
Trials (%) Published trials (%) Unpublished trials (%)
Negative result 2 (4)a 2 (4) 0 (0)a
Neutral result 14 (26)a 10 (21) 4 (57)a
Positive result 38 (70)a 35 (74) 3 (43)a
Unknown result 8 0 8
Total 62 47 15
a Computed percentage omits trials with ‘‘Unknown’’ results.
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and ‘‘CPOE’’ (computerized provider order entry) for all trials reg-
istered with ClinicalTrials.gov from 2000 to 2008. Trials were re-
viewed and excluded if they did not involve a primary
intervention that was use of an electronic health record, use of
an electronic prescribing or ordering system, or delivery of elec-
tronic reminders. Those found to be in scope were reviewed by
the authors to ascertain whether the trial was completed and
whether it was published in a peer-reviewed journal.
Publication was determined by reviewing the ClinicalTrials.gov
record, which occasionally listed publications, by searching Pub-
Med, and by contacting trial investigators. The authors (DKV and
GH) searched PubMed for all publications by all personnel listed in
the ClinicalTrials.gov record. If no relevant publication was found,
then secondary search termswereused, suchas thenameof the trial,
the sponsoring consortium, or the location of the trial. If still no pub-
lication was identiﬁed for a trial, the authors attempted to contact
the principal investigator listed in ClinicalTrials.gov to determine
the trial results and whether there was a resulting publication.
Trials were considered ‘‘completed’’ if the Recruitment or Com-
pletion Date ﬁelds of the ClinicalTrials.gov record indicated that
they were completed by 2009 or if there was a deﬁnitive publica-
tion by the investigators. Completed here implies that a sufﬁcient
portion of the trial was completed to allow for publication of re-
sults, even though aspects of the trial may have been ongoing. If
trial status was not recorded by December 2009 and there was
no publication through July 2012, they were considered ‘‘missing
publication.’’ If trials were designated as completed or expected
to be completed after July 2012, then they were considered ‘‘ongo-
ing’’ (even if the intervention was over, there may have been insuf-
ﬁcient time to publish results).
Trials with one or more publications were then categorized
using the framework of Buntin et al. [4] as being positive (including
trials with mixed results that were predominantly positive), neu-
tral (no effect), or negative (meaning actually harmful). Broadly
speaking, most studies involving health information technology
have mixed results. For example, an EHR reminder might improve
adherence for a quality measure at the expense of requiring extra
time or additional mouse clicks for clinicians. In our categorization,
positive outcomes were recorded when health information tech-
nology was associated with improvement in one or more aspects
of care, and in the case of mixed results, the overall conclusion of
the study authors was that the positive effects of technology out-
weighed the negative effects. Negative outcomes were recorded
when the negative effects of the technology intervention out-
weighed the positive effects. A neutral rating was given when
the study reported no demonstrable change in care.3. Results
The results are shown in Table 1. One hundred twelve trials
were identiﬁed in ClinicalTrials.gov using the search phrases; 85
were found to be within scope, and 62 were completed. Of com-
pleted trials, 76% had publications that described trial results. Most
publications (74%) reported positive results, with 21% reporting
neutral results and 4% reporting negative (harmful) results. Of
the 24% of completed trials that had no publications, 8 were stud-
ies where the principal investigator (PI) listed in ClinicalTrials.gov
did not respond to our repeated requests for information (in one
instance, the PI was deceased), 3 were studies where the PI re-
ported positive results, and 4 were studies where the PI reported
neutral results. PIs identiﬁed several reasons for the lack of publi-
cations about a trial, such as: key members had left the project
team, they were too busy or had not had sufﬁcient time to publish,
and their manuscript was rejected by journal editors.4. Discussion
Two particular issues may affect our results. First, in the initial
years of ClinicalTrials.gov, the resource was not well known so few
trials were registered. Moreover, the few trials that were registered
may have been unusual (e.g., investigators may have registered tri-
als that were more likely to be published), and the data were fre-
quently unreliable (e.g., in several cases, the completion date
preceded the start date). Before 2005, there were only zero to three
registered EHR studies per year; after that there were ﬁve or more.
The second concern is that the recent trials may not have had en-
ough time to be published. The mean and median time to publica-
tion were 4.3 years and 4.1 years, respectively. Based on these data
and on knowledge of the publication process, most trials com-
pleted by 2007 should have had enough time to be published. Tak-
ing only trials that completed between 2005 and 2007 (inclusive),
75% were published and 25% were not, corroborating our main re-
sult. Therefore, despite concerns on either end, our overall non-
publication result of 24% appears to be reasonable.
The classiﬁcation of study results was performed by the two
authors together; the study may be limited by the fact that no for-
mal calculation of inter-observer agreement was made. Neverthe-
less, our analysis does provide bounds to the proportion of
registered trials with positive results. Depending on the outcome
of trials with missing results, the number of positive trials ranged
from 61% to 74%. In 7 unpublished trials for which trial investiga-
tors reported results, 3 studies were positive and 4 were neutral.
Thus, unpublished trials were less likely to have positive results
(3/7) compared to published trials (35/47, p < 0.001). In other eval-
uations of publication bias, trials with missing results were more
likely to be negative or neutral than positive [11,12].
Assuming that the disposition of trials with missing results is
similar to other unpublished trials, our best estimate is that
approximately 67% of EHR trials had positive results. This is some-
what less than the 92% reported by Buntin et al. [4]. Other than
publication bias, several reasons may account for the difference.
Our study focused speciﬁcally on electronic health records, while
Buntin’s review also included telemedicine, administrative func-
tions, information retrieval, patient registries, health information
exchange, and personal health records. Moreover, our study exam-
ined only trials registered in ClinicalTrials.gov. This repository does
not contain a comprehensive listing of all studies of health infor-
mation technology interventions. For example, studies where indi-
vidual subjects are not considered to be ‘‘at risk’’ from the
intervention may not require trial registration according to ICMJE
or other policies. It is conceivable that the sample of EHR studies
that were registered in ClinicalTrials.gov had a greater likelihood
of being published than the larger population of all studies of
EHR from the same time period. Thus, our ﬁndings may overesti-
mate the publication rate for EHR interventions.
Our study complements that of Ammenwerth and de Keizer
[13], who used a survey to assess non-publication of medical infor-
matics studies. While the response rate was low, they found that
over one-third of studies are not published, a ﬁnding that is close
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tion, including the results not being of interest for others, the pub-
lication being in preparation, not having time for publication,
limited scientiﬁc quality of the study, political or legal reasons,
and the study only being conducted for internal use. Several of
these reasons would not be relevant to trials registered in Clinical-
Trials.gov. Machan et al. [14] reported a similar rate of positive pub-
lished study results (69.8%) to ours (74%).
Other investigators have used ClinicalTrials.gov to study publi-
cation outcomes [15]. In 2007, Ross et al. examined a cross-section
of all trials registered in ClinicalTrials.gov, ﬁnding that of trials that
ended by 2004 had a 61% publication rate [16]. Bourgeois and col-
leagues reported a 66.3% publication rate for drug trials registered
in Clinical Trials.gov [17]. These ﬁndings suggest that the rate of
non-publication for studies of EHRs in this data set is comparable
to other types of studies. Bourgeois and colleagues found a statis-
tically signiﬁcant difference in the outcomes of studies that were
funded by industry (85.4%) compared with government (50.0%)
and nonproﬁt or nonfederal organizations (71.9%) [17]. We did
not have a large enough sample to stratify our results according
to funding source, but it is possible that published outcomes of
EHR studies may be inﬂuenced by this parameter.
There is no simple answer to the question of how many studies
‘‘ought’’ to be positive. Even if electronic health records are gener-
ally beneﬁcial, as researchers develop innovative interventions and
employ clinical equipoise in designing trials, one may expect some
substantial number to be positive, another substantial number to
be neutral (due to failed innovations, unsuccessful implementa-
tions of efﬁcacious interventions, and underpowered studies),
and a small number to be negative (harmful). This is consistent
with our results.
5. Implications
Our results demonstrate that there is a moderate amount of
non-publication of EHR trials, and that the rate is in line with that
of other areas. Such non-publication may lead to publication bias.
This ﬁnding has several implications.
Investigators and publishers should continue to be encouraged
to disseminate neutral and negative results [18]. In the still-nas-
cent ﬁeld of health information technology, it is just as important
to understand why systems fail as it is to learn about why they suc-
ceed. Research investigators who also happen to be the developers
or implementers of health information technology should recog-
nize the subtle ways that they may be inﬂuenced by their preexist-
ing belief in the technology’s value [19] and how this may affect
their own likelihood to publish the results. Publishers should also
be mindful of the developer–evaluator bias, perhaps recommend-
ing manuscript authors to provide a disclosure of such ‘‘personal’’
conﬂicts of interest in the same way ﬁnancial conﬂicts are cur-
rently revealed. Additional research could be conducted to assess
differences in publication rates and outcomes for studies based
on whether the evaluator of a system or application also plays a
key role in its development or implementation.
Policymakers should be aware that publication bias likely has
some effect on meta-analyses of studies, such as the recent evalu-
ation performed by Buntin et al. [4]. Health information technology
meta-analyses should comment speciﬁcally on the possibility of
non-publication and should estimate the range of its likely effect
on the results of the analysis.
Our main implication, however, is that the rate of non-publica-
tion of EHR studies does not appear to be larger than in other do-
mains. There may be a small inﬂation of the proportion of positive
trials published, but the potential difference probably is not large
enough to warrant undue concern. Based on our data, it is likelythat the majority of EHR studies produce positive results. Never-
theless, publication of negative results remains essential; indeed,
such studies have provided substantial beneﬁt by warning
would-be adopters of implementation pitfalls as well as alerting
the EHR software development community of problems that need
to be addressed [20–22].
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